Efficacy, Safety and Pharmacokinetics of Up to Two Courses of the Rituximab Biosimilar CT-P10 Versus Innovator Rituximab in Patients with Rheumatoid Arthritis: Results up to Week 72 of a Phase I Randomized Controlled Trial.
scientific article published on 13 June 2017
Author/s
author: Chang-hee Suh, Seung Cheol Shim, Pavel Shesternya, Piotr Wiland, Dae Hyun Yoo, Slawomir Jeka, Francisco Fidencio Cons Molina, Pawel Hrycaj, Francisco G Medina-Rodriguez, Sebastiao Radominski, Marina Stanislav, Dong Hyuk Sheen, Leysan Myasoutova, Mie Jin Lim, Young Sung Lee
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.